FGFR3 and neoplasm: We used the three groups, TaG3, T1, and T2–4, previously defined for the FGFR3-non-mutated pathway and the three groups, TaG1G2, T1, and T2–4 for the FGFR-mutated tumor pathway (Figure 5).